Skip to main content

Find Clinical Trials

Home
Conditions
Pathologically Proven Stage I, II and III Non-Small Cell Lung Cancer (NSCLC)

Clinical trial condition

Pathologically Proven Stage I, II and III Non-Small Cell Lung Cancer (NSCLC)

Explore clinical trials studying Pathologically Proven Stage I, II and III Non-Small Cell Lung Cancer (NSCLC). Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Pathologically Proven Stage I, II and III Non-Small Cell Lung Cancer (NSCLC) trial results

Completed

Analysis of the Incidence of Expression of Tumor Antigens in Pathologically Proven Stage I, II and III Non-Small Cell Lung Cancer(NSCLC) in Asiatic Patients

NCT01837511

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: GSK Investigational Site Singapore

GSK Investigational Site Seoul, South Korea

GSK Investigational Site Songpa-gu, Seoul, South Korea

View Trial Details